Breaking News Instant updates and real-time market news.

ARR

ARMOUR Residential

$22.49

0.02 (0.09%)

, CIM

Chimera

$17.16

0.28 (1.66%)

07:41
11/30/16
11/30
07:41
11/30/16
07:41

Deutsche Bank to hold a conference

2016 Mortgage REIT 1:1 Day is being held in New York on November 30.

ARR

ARMOUR Residential

$22.49

0.02 (0.09%)

CIM

Chimera

$17.16

0.28 (1.66%)

EFC

Ellington Financial

$16.06

-0.17 (-1.05%)

LADR

Ladder Capital

$14.52

-0.03 (-0.21%)

MFA

MFA Financial

$7.85

0.01 (0.13%)

SLD

Sutherland Asset Management

$13.15

0.1 (0.77%)

TWO

Two Harbors

$8.67

0.19 (2.24%)

WMC

Western Asset Mortgage

$10.80

0.14 (1.31%)

  • 30

    Nov

ARR ARMOUR Residential
$22.49

0.02 (0.09%)

05/04/16
LTCO
05/04/16
DOWNGRADE
LTCO
Neutral
ARMOUR Residential downgraded to Neutral from Buy at Ladenburg
Ladenburg Thalmann analyst David Walrod downgraded ARMOUR Residential to Neutral saying the valuation is no longer compelling after the company's book value declined 12.6% to $24.48 per share in Q1.
02/24/16
NOMU
02/24/16
DOWNGRADE
Target $16
NOMU
Reduce
ARMOUR Residential downgraded to Reduce from Neutral at Nomura
Nomura analyst Brock Vandervliet downgraded ARMOUR to Reduce and lowered his price target to $16 from $23 on shares. The analyst said ARMOUR has the worst economic returns across coverage in 2015 and expects trends to continue this year given its unsuccessful portfolio construction and high leverage.
02/24/16
02/24/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Ford (F) downgraded to Underperform at Credit Suisse by analyst Dan Galves, who said the automaker's North America EBIT guidance is at risk on overly optimistic implied volumes. He also sees global inventory as conflicting with global demand and material cost increases have fully offset recent pricing/mix gains from new product launches. 2. PTC Therapeutics (PTCT) downgraded to Neutral and Sector Perform to Citi and RBC Capital, respectively, after the FDA refused to review the company's application for Translarna for the treatment of Duchenne muscular dystrophy. Citi analyst Joel Beatty said the refusal most likely suggests that PTC will need additional clinical data before refiling, which could be "expensive and risky." 3. The Advisory Board (ABCO) downgraded at Stifel, Cantor, Craig-Hallum and Avondale after the company's Q4 revenue and FY16 guidance came in below expectations. Cantor analyst Joseph Foresi said the company reported a "surprising, material slowdown" in its Healthcare growth rate and Craig-Hallum analyst Matt Hewitt added that the company's exposure on the software side as ICD-10 related revenues fell the hardest and views shares as fully valued in the near-term. 4. ARMOUR Residential (ARR) downgraded to Reduce at Nomura by analyst Brock Vandervliet, who said the company has the worst economic returns across coverage in 2015 and expects trends to continue this year given its unsuccessful portfolio construction and high leverage. 5. Yamana Gold (AUY) downgraded to Sell at Goldman, with analyst Andrew Quail saying that the company's fiscal position will "remain pressured" over the next year now that Cerro Moro has been delayed until Q1 of 2018. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/03/16
SBSH
03/03/16
UPGRADE
Target $7.14
SBSH
Neutral
JAVELIN Mortgage upgraded to Neutral from Sell at Citi
Citi analyst Donald Fandetti upgraded JAVELIN Mortgage (JMI) to Neutral citing the acquisition offer from ARMOUR Residential (ARR). The analyst raised his price target for the shares to $7.14 from $6.
CIM Chimera
$17.16

0.28 (1.66%)

05/04/16
WELS
05/04/16
DOWNGRADE
WELS
Underperform
Chimera downgraded to Underperform from Market Perform at Wells Fargo
Wells Fargo analyst Joel Houck downgraded Chimera Investment to Underperform saying the company's "premium valuation" to peers is unwarranted. The analyst expects the cost advantage of refinancing legacy residential credit deals to come under pressure in 2016 and 2017. He has a $12.25-$13.25 price target range for the shares.
01/15/16
WELS
01/15/16
DOWNGRADE
WELS
Market Perform
Chimera downgraded to Market Perform from Outperform at Wells Fargo (pre-open)
EFC Ellington Financial
$16.06

-0.17 (-1.05%)

04/21/16
FBRC
04/21/16
INITIATION
Target $20.5
FBRC
Outperform
Ellington Financial initiated with an Outperform at FBR Capital
Target $20.50.
LADR Ladder Capital
$14.52

-0.03 (-0.21%)

02/23/16
KBWI
02/23/16
DOWNGRADE
Target $13
KBWI
Market Perform
Ladder Capital downgraded to Market Perform from Outperform at Keefe Bruyette
Keefe Bruyette analyst Jade Rahmani downgraded Ladder Capital to Market Perform with a $13 price target citing a lack of near-term catalysts and uncertainty regarding CMBS issuance.
02/19/16
WELS
02/19/16
DOWNGRADE
WELS
Market Perform
Ladder Capital downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Joel Houck downgraded Ladder Capital to Market Perform saying the conduit lending environment remains "highly sub-optimal." The analyst has a $12.00-$12.50 price target range for the shares.
MFA MFA Financial
$7.85

0.01 (0.13%)

04/11/16
WELS
04/11/16
DOWNGRADE
WELS
Underperform
MFA Financial downgraded to Underperform from Market Perform at Wells Fargo
Wells Fargo analyst Joel Houck downgraded MFA Financial to Underperform following the release of his Q1 book value estimates for Agency REITs. The analyst lowered his price target range for the shares to $5.75-$6.25 from $6.00-$6.50.
09/06/16
FBRC
09/06/16
DOWNGRADE
Target $7.5
FBRC
Market Perform
MFA Financial downgraded to Market Perform from Outperform at FBR Capital
FBR Capital analyst Jessica Levi-Ribner downgraded MFA Financial to Market Perform saying the shares are fairly valued at current levels. The analyst kept a $7.50 price target for the shares.
01/26/16
01/26/16
UPGRADE

On The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AMC Entertainment (AMC) upgraded on valuation, 2017 outlook at RBC Capital... America Movil upgraded to Overweight from Equal Weight at Morgan Stanley... BNC Bancorp (BNCN) upgraded to Buy from Hold at Gabelli... Casella Waste (CWST) upgraded to Strong Buy from Outperform at Raymond James... Cenovus Energy (CVE) upgraded to Buy from Neutral at Goldman... Cracker Barrel (CBRL) upgraded to Buy from Neutral at SunTrust... D.R. Horton (DHI) upgraded to Buy from Hold at Zelman... Edison International (EIX) upgraded to Buy from Hold at Evercore ISI... First Financial Bancorp (FFBC) upgraded to Buy from Hold at Sandler O'Neill... Hartford Financial (HIG) upgraded to Overweight from Neutral at Atlantic Equities... Heartland Financial (HTLF) upgraded to Buy from Hold at Sandler O'Neill... MFA Financial (MFA) upgraded to Overweight from Neutral at JPMorgan... National General (NGHC) upgraded to Overweight at Morgan Stanley... Navios Maritime Partners (NMM) upgraded to Overweight from Neutral at JPMorgan... PG&E (PCG) upgraded to Buy from Hold at Evercore ISI... SBA Communications (SBAC) upgraded to Buy from Hold at Stifel... Sally Beauty (SBH) upgraded to Outperform from Perform at Oppenheimer... Sanmina (SANM) upgraded to Neutral from Sell at Citi... Scorpio Bulkers (SALT) upgraded to Overweight from Neutral at JPMorgan... Southern Company (SO) upgraded to Hold from Sell at Evercore ISI... Southern Copper (SCCO) upgraded to Overweight from Neutral at JPMorgan... Vodafone (VOD) upgraded to Buy from Hold at Jefferies.
06/15/16
COMP
06/15/16
DOWNGRADE
COMP
Sell
MFA Financial downgraded to Sell from Neutral at Compass Point
SLD Sutherland Asset Management
$13.15

0.1 (0.77%)

TWO Two Harbors
$8.67

0.19 (2.24%)

01/15/16
WELS
01/15/16
DOWNGRADE
WELS
Market Perform
Two Harbors downgraded to Market Perform from Outperform at Wells Fargo
11/03/16
WELS
11/03/16
UPGRADE
WELS
Outperform
Two Harbors upgraded to Outperform from Market Perform at Wells Fargo
09/06/16
FBRC
09/06/16
DOWNGRADE
Target $9
FBRC
Market Perform
Two Harbors downgraded to Market Perform from Outperform at FBR Capital
FBR Capital analyst Jessica Levi-Ribner downgraded Two Harbors Investment to Market Perform saying the shares are fairly valued at current levels. The analyst raised her price target for the stock to $9 from $8.50.
11/04/16
WELS
11/04/16
UPGRADE
WELS
Outperform
Two Harbors upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Joel Houck last night upgraded Two Harbors Investment to Outperform from Market Perform saying he sees a "strong case" for fundamental earnings growth following the company's Q3 results. The analyst raised his price target range for the shares to $9.00-$9.50 from $8.50-$9.00.
WMC Western Asset Mortgage
$10.80

0.14 (1.31%)

06/29/16
BOFA
06/29/16
DOWNGRADE
BOFA
Neutral
Western Asset Mortgage downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst Kenneth Bruce downgraded Western Asset to Neutral and lowered its price target to $9.50 from $10. The analyst believes shares will lose their premium to the group due to declining ROE that is now in line with the group.
06/27/16
WDLK
06/27/16
UPGRADE
Target $9.5
WDLK
Hold
Western Asset Mortgage upgraded to Hold from Sell at Wunderlich
Wunderlich analyst Merrill Ross upgraded Western Asset Mortgage Capital to Hold saying the company's dividend now looks sustainable after six cuts. The analyst has a $9.50 price target for the shares.
05/10/16
WDLK
05/10/16
DOWNGRADE
Target $8
WDLK
Sell
Western Asset Mortgage downgraded to Sell from Hold at Wunderlich
Wunderlich analyst Merrill Ross downgraded Western Asset Mortgage to Sell with an $8 price target.
04/11/16
WELS
04/11/16
DOWNGRADE
WELS
Underperform
Western Asset Mortgage downgraded to Underperform from Market Perform at Wells Fargo
Wells Fargo analyst Joel Houck downgraded Western Asset Mortgage to Underperform from Market Perform following the release of his Q1 book value estimates for Agency REITs. The analyst lowered his price target range for the shares to $8.00-$8.50 from $8.50-$9.00.

TODAY'S FREE FLY STORIES

RHHBY

Roche

$27.67

0.47 (1.73%)

20:25
12/05/16
12/05
20:25
12/05/16
20:25
Conference/Events
Roche to hold an analyst meeting »

Analyst Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

AZO

AutoZone

$776.42

-7.32 (-0.93%)

, HDS

HD Supply

$39.75

0.67 (1.71%)

20:25
12/05/16
12/05
20:25
12/05/16
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

AZO

AutoZone

$776.42

-7.32 (-0.93%)

HDS

HD Supply

$39.75

0.67 (1.71%)

MIK

Michaels

$24.31

0.34 (1.42%)

TOL

Toll Brothers

$30.47

1.15 (3.92%)

BOBE

Bob Evans

$46.77

1.05 (2.30%)

CONN

Conn's

$11.20

0.4 (3.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 06

    Dec

  • 06

    Dec

  • 06

    Dec

  • 06

    Dec

  • 06

    Dec

  • 14

    Dec

  • 09

    Jan

GDDY

GoDaddy

$34.74

1.45 (4.36%)

20:14
12/05/16
12/05
20:14
12/05/16
20:14
Hot Stocks
GoDaddy acquires WP Curve »

WP Curve announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDC

Belden

$74.99

0.9 (1.21%)

20:10
12/05/16
12/05
20:10
12/05/16
20:10
Earnings
Belden sees FY17 adjusted EPS $5.00-$5.25, consensus $5.23 »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

SGMO

Sangamo

19:39
12/05/16
12/05
19:39
12/05/16
19:39
Hot Stocks
Sangamo reports preclinical, manufacturing data on SB-525, says IND on track »

Sangamo BioSciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

SGEN

Seattle Genetics

$66.26

-0.44 (-0.66%)

, BMY

Bristol-Myers

$55.55

-0.41 (-0.73%)

19:38
12/05/16
12/05
19:38
12/05/16
19:38
Hot Stocks
Seattle Genetics, Bristol-Myers: Data supports ADCETRIS, Opdivo combo »

Seattle Genetics (SGEN)…

SGEN

Seattle Genetics

$66.26

-0.44 (-0.66%)

BMY

Bristol-Myers

$55.55

-0.41 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

LGIH

LGI Homes

$32.34

0.45 (1.41%)

19:36
12/05/16
12/05
19:36
12/05/16
19:36
Hot Stocks
LGI Homes reports November home closings up 28.9% y/y »

LGI Homes announced 321…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CELG

Celgene

$116.56

-1.07 (-0.91%)

19:36
12/05/16
12/05
19:36
12/05/16
19:36
Hot Stocks
Celgene reports analysis of three CC-486 studies »

Celgene announced results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

BLUE

bluebird bio

$72.15

2.4 (3.44%)

19:35
12/05/16
12/05
19:35
12/05/16
19:35
Hot Stocks
bluebird bio provides updates on HSC gene therapy programs »

bluebird bio provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGIO

Agios Pharmaceuticals

$49.88

-7.09 (-12.45%)

19:33
12/05/16
12/05
19:33
12/05/16
19:33
Hot Stocks
Agios 'encouraged' by durable clinical activity of AG-120 »

Agios Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$60.25

-0.88 (-1.44%)

19:31
12/05/16
12/05
19:31
12/05/16
19:31
Hot Stocks
Merck: KEYNOTE-087 trial data shows oORR of 69%, CRR of 22.4% »

Merck announced updated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 08

    Mar

TWX

Time Warner

$93.34

-0.46 (-0.49%)

, T

AT&T

$38.63

0.02 (0.05%)

19:29
12/05/16
12/05
19:29
12/05/16
19:29
Periodicals
Time Warner 'struggling to expand' HBO Now, NY Post says »

Time Warner (TWX) is…

TWX

Time Warner

$93.34

-0.46 (-0.49%)

T

AT&T

$38.63

0.02 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

  • 07

    Dec

BP

BP

, REPYY

Repsol

$13.88

0.25 (1.83%)

19:18
12/05/16
12/05
19:18
12/05/16
19:18
Periodicals
BP acquires Repsol stake in Indonesia LNG plant, Reuters says »

BP (BP) has purchased…

BP

BP

REPYY

Repsol

$13.88

0.25 (1.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOSUF

Fosun

19:12
12/05/16
12/05
19:12
12/05/16
19:12
Hot Stocks
Liberty Mutual to acquire Fosun subsidiary Ironshore for roughly $3B »

Liberty Mutual Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$49.75

-0.06 (-0.12%)

, YHOO

Yahoo

$40.20

0.13 (0.32%)

18:54
12/05/16
12/05
18:54
12/05/16
18:54
Periodicals
AOL CEO 'cautiously optimistic' Verizon-Yahoo deal will go through, WSJ says »

AOL CEO Tim Armstrong…

VZ

Verizon

$49.75

-0.06 (-0.12%)

YHOO

Yahoo

$40.20

0.13 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 24

    Jan

TUWOY

Tullow Oil

$2.06

0.109 (5.58%)

18:46
12/05/16
12/05
18:46
12/05/16
18:46
Downgrade
Tullow Oil rating change  »

Tullow Oil downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GBNK

Guaranty Bancorp

$22.15

0.75 (3.50%)

18:43
12/05/16
12/05
18:43
12/05/16
18:43
Hot Stocks
Breaking Hot Stocks news story on Guaranty Bancorp »

Castle Creek raises stake…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATKR

Atkore

$20.48

-0.18 (-0.87%)

18:41
12/05/16
12/05
18:41
12/05/16
18:41
Syndicate
Atkore files to sell 8M shares of common stock for holders »

The offering is being…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTX

United Technologies

$107.42

-0.8 (-0.74%)

18:38
12/05/16
12/05
18:38
12/05/16
18:38
Hot Stocks
United Technologies CEO: No quid pro quo on taxes in Carrier deal with Trump »

Says Carrier agreement…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPDN

Professional Diversity Network

$9.75

-0.01 (-0.10%)

18:37
12/05/16
12/05
18:37
12/05/16
18:37
Hot Stocks
Breaking Hot Stocks news story on Professional Diversity Network »

North Star cuts passive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHXM

DHX Media

$5.05

-0.36 (-6.65%)

18:33
12/05/16
12/05
18:33
12/05/16
18:33
Hot Stocks
Breaking Hot Stocks news story on DHX Media »

Luxor Capital cuts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPHS

Trinity Place

$10.02

0.08 (0.80%)

18:24
12/05/16
12/05
18:24
12/05/16
18:24
Hot Stocks
Trinity Place Holdings, Pacolet Milliken acquire Brooklyn building for $68.8M »

Trinity Place Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SU

Suncor

$32.46

0.23 (0.71%)

18:07
12/05/16
12/05
18:07
12/05/16
18:07
Hot Stocks
Suncor Energy resolves C$1.3B tax dispute with Canada Revenue Agency »

Suncor Energy reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLRN

Acceleron

$34.90

-1.39 (-3.83%)

, CELG

Celgene

$116.56

-1.07 (-0.91%)

18:07
12/05/16
12/05
18:07
12/05/16
18:07
Hot Stocks
Acceleron, Celgene report Phase 2 data on luspatercept in beta-thalassemia »

Acceleron Pharma (XLRN)…

XLRN

Acceleron

$34.90

-1.39 (-3.83%)

CELG

Celgene

$116.56

-1.07 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

SNSS

Sunesis

$4.02

0.12 (3.08%)

17:54
12/05/16
12/05
17:54
12/05/16
17:54
Hot Stocks
Sunesis says new VALOR trial data show 'compelling durable survival outcomes' »

Sunesis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.